Resource Center

Always with a focus on innovation, find resources that share our scientific experts passion and knowledge. Find case studies, info sheets, posters and more.
Mountain range with trees and river
Sustainability

Quotient Sciences 2023 ESG Report

10 December 2024 Download

161 - 170 of 220 results

Scientific Poster, Bioanalysis
Analysis of Ranitidine Reference Materials Using a Six N-Nitrosamine LC-MS/MS Assay
Download Now
Scientific Poster, Bioanalysis
EBF 2021: Novel Copper Protein Speciation Method for Calculating Serum Non Ceruloplasmin Copper: A Comparative Analysis
Download Now
Scientific Poster, Bioanalysis
EBF 2021: Analysis of Ranitidine Reference Materials Using a Six N-Nitrosamine LC-MS/MS Assay
Download Now
Scientific Poster, Solubility Enhancement, Modified Release, Modelling & Simulation
AAPS 2021: Development and Application of a PBPK Model Using Theoretical Particle Size Distribution to Describe in vivo D issolution to Predict the Impact of Formulation Changes on Oral Bioavailability of GB001
Download Now
Scientific Poster, Pediatrics, Drug Product Optimization
EuPFI 2021: Taste Assessment Study of Belumosudil to Inform an Integrated Pediatric Formulation Development Program
Download Now
Scientific Poster, Pediatrics, Formulation Development
EuPFI 2021: Development of a Novel Pediatric Belumosudil Oral Suspension
Download Now
Scientific Poster, Modified Release
CRS 2021 Poster: Using formulation design spaces and clinical data to optimize development of modified release (MR) dosage forms
Download Now
Scientific Poster, Clinical Pharmacology, First-in-Human
ASCPT 2021 Poster: A First in Human (FIH) Study to Assess the Safety, Tolerability and Pharmacokinetics of Single and Multiple Doses, and Alternative Formulations of R941552 (R552): A selective Receptor Interacting Protein 1 (RIP1) Kinase Inhibitor
Download Now
Scientific Poster, Clinical Pharmacology
HBI-3000: A Novel Drug for Conversion of Atrial Fibrillation - Phase 1 Study Results
Download Now
Scientific Poster, Clinical Trial Manufacturing, Formulation Development, First-in-Human
How do I quickly develop first-in-human (FIH) dosage forms and avoid CMC delays whilst achieving proof-of-concept (POC)?
Download Now
Get in touch
Humanity can't afford to wait, so neither can we.
Let's talk